This Week at FDA: ACIP signs off on bivalent boosters

This Week at FDAThis Week at FDABiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy